Weight-loss drugs and surgery may clear fatty liver disease in adults with high BMI

Fatty liver disease is becoming more common as obesity rates rise. For many adults, this condition leads to inflammation and scarring that can damage the liver over time. A recent large review looked at how different treatments affect this disease in people with a BMI of 27 or higher who have confirmed liver scarring. The study compared weight-loss medications like tirzepatide and semaglutide, lifestyle changes, and surgical options like sleeve gastrectomy against standard care or a placebo. The main goal was to see if these treatments could clear the liver fat without making the scarring worse. The results showed that the medications and surgeries were better than standard care at helping the liver heal. People who lost more weight tended to see better results in their liver scans. However, the review noted that the evidence base was limited and the connections between different treatment groups were weak. Because of this, the findings should be seen as exploratory and hypothesis-generating rather than definitive proof. The authors emphasize that more direct trials are needed to confirm these results before changing medical practice.